| P50 | author | Helen L Petsky | Q56809158 |
| | Christopher Cates | Q73513485 |
| | Catherine Turner | Q37830417 |
| | Anne B Chang | Q46601108 |
| P2093 | author name string | Jennifer A Kynaston | |
| | Albert Li | |
| P2860 | cites work | Exhaled nitric oxide in the management of childhood asthma: A prospective 6-months study | Q59436485 |
| | Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma | Q74363456 |
| | The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control | Q74493889 |
| | Facing the challenges of childhood asthma: what changes are necessary? | Q81606172 |
| | Daily ambulatory exhaled nitric oxide measurements in asthma | Q83281501 |
| | Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial | Q24655820 |
| | Non-eosinophilic asthma: importance and possible mechanisms | Q28394141 |
| | ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. | Q34409752 |
| | Use of exhaled nitric oxide measurements to guide treatment in chronic asthma | Q34421179 |
| | The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial | Q34627601 |
| | Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma | Q35532923 |
| | Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma | Q35534832 |
| | Exhaled nitric oxide and asthma: complex interactions between atopy, airway responsiveness, and symptoms in a community population of children. | Q35535591 |
| | Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma | Q35563919 |
| | Exhaled nitric oxide in childhood asthma--time to use inflammometry rather than spirometry? | Q35883878 |
| | Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics | Q40315613 |
| | Exhaled nitric oxide in a population-based study of asthma and allergy in schoolchildren | Q40514388 |
| | Role of nasal nitric oxide in the resolution of experimental rhinovirus infection | Q43538398 |
| | Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship | Q44162549 |
| | Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children | Q44650811 |
| | Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma | Q46309541 |
| | Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial | Q46565002 |
| | Exhaled nitric oxide in healthy nonatopic school-age children: determinants and height-adjusted reference values | Q47337218 |
| | Exhaled nitric oxide as a screening tool for asthma in school children | Q47799251 |
| | Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children | Q47849250 |
| | A community study of exhaled nitric oxide in healthy children. | Q52228414 |
| P433 | issue | 4 | |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | CD006340 | |
| P577 | publication date | 2009-10-07 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults | |